82 results
424B5
VINC
Vincerx Pharma Inc
29 Apr 24
Prospectus supplement for primary offering
5:14pm
TAX CONSIDERATIONS FOR HOLDERS OF COMMON STOCK, PRE-FUNDED WARRANTS OR COMMON WARRANTS
S-20
UNDERWRITING
S-27
LEGAL MATTERS
S-31
EXPERTS
S-31
WHERE YOU …
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR HOLDERS OF COMMON STOCK, PRE-FUNDED WARRANTS OR COMMON WARRANTS
The following is a discussion
8-K
EX-1.1
VINC
Vincerx Pharma Inc
26 Apr 24
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
5:05pm
of such trials, copies of which communications have been made available to you.
(xxxi) Payment of Taxes. All United States federal income tax returns … in conformity with GAAP. The United States federal income tax returns of the Company through the fiscal year ended December 31, 2023 have been settled
8-K
EX-4.2
VINC
Vincerx Pharma Inc
26 Apr 24
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
5:05pm
to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes … , as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees
8-K
EX-4.1
VINC
Vincerx Pharma Inc
26 Apr 24
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
5:05pm
for shares of Common Stock upon exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax, transfer agent fee … or other incidental tax or expense (excluding any applicable stamp duties) in respect of the issuance of such certificates, all of which taxes and expenses
424B5
VINC
Vincerx Pharma Inc
25 Apr 24
Prospectus supplement for primary offering
4:10pm
STATEMENTS
S-12
USE OF PROCEEDS
S-14
DILUTION
S-15
DESCRIPTION OF WARRANTS
S-17
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR HOLDERS OF COMMON … forms of consideration in connection with the change of control.
S-19
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR HOLDERS OF COMMON STOCK, PRE
8-K
EX-10.1
kic089
29 Mar 24
Entry into a Material Definitive Agreement
4:12pm
424B5
da1n1u80iwt4x8 ec
29 Mar 24
Prospectus supplement for primary offering
4:04pm
8-K
EX-99.1
kffid7d lf2jfvhe4x
29 Mar 22
Vincerx Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
8:06am
424B3
4y94xh8qkpgtpdb
28 Jan 22
Prospectus supplement
5:18pm
S-3
2b8px0
19 Jan 22
Shelf registration
4:03pm